DNA topoisomerase IIα and -β expression in human ovarian cancer
Authors:
Open Access
- 29 January 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (5-6) , 748-753
Abstract
To study DNA topoisomerase IIα (Topo-IIα) and -β expression and regulation in human ovarian cancer, 15 ovarian tumour samples were investigated. To compare different levels of expression, the samples were screened for topo IIα and -β mRNA with Northern blotting and a quantitative reverse transcriptase polymerase chain reaction (RT-PCR) assay for Topo-IIα mRNA. Additionally, protein levels were determined with Western blotting and topoisomerase II activity levels with the decatenation assay. The results obtained were compared with each other and with the tumour volume index of the samples. In tumours with a tumour volume index ≥ 50%, the mRNA levels (as determined by Northern blotting) and protein levels for each isozyme were in accordance. Additionally, correlations were found between Topo-IIα RT-PCR data and Topo-IIα Northern blot results, and between Topo-IIα RT-PCR data and Topo-IIα protein levels. Interestingly, Topo-IIβ protein levels correlated better with Topo-II activity than Topo-IIα protein levels. In eight ovarian cystadenoma samples, no Topo-IIα protein could be found. In only three out of eight of these cystadenomas, Topo-IIβ protein could be detected. These findings suggest that Topo-IIα and Topo-IIβ protein levels are up-regulated in ovarian cancer and may indicate that Topo-IIβ is an interesting target for chemotherapy in ovarian tumours.Keywords
This publication has 35 references indexed in Scilit:
- Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme ActivitiesJournal of Cell Biology, 1997
- Cell Biological Markers of Drug Resistance in Ovarian CarcinomaGynecologic Oncology, 1995
- Resistance‐associated factors in human small‐cell lung‐carcinoma GLC4 sub‐lines with increasing adriamycin resistanceInternational Journal of Cancer, 1995
- Options for Primary Chemotherapy of Epithelial Ovarian Cancer: TaxanesGynecologic Oncology, 1994
- Cytotoxic activity of topoisomerase II inhibitors in primary cultures of tumor cells from patients with human hematologic and solid tumorsCancer, 1994
- High mdrl- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemiasCancer Letters, 1994
- Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cellsBritish Journal of Haematology, 1993
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970